Kef-1, an ACE-inhibiting peptide derived from kefir fermentation, reduced blood pressure, oxidative stress, and vascular damage in a mouse model of hypertension.
ACE inhibitor from kefirKef-1 inhibits the same enzyme targeted by prescription blood pressure drugs, and showed anti-hypertensive effects in a mouse model
What the researchers found
Kef-1 peptide reduced ROS production and improved vascular structure in 2K1C mice.
Why it matters
Understanding how Kef-1 works could lead to new treatments for hypertension and related cardiovascular diseases. This research highlights the potential of natural compounds in managing health conditions.
How the study worked
The study used an angiotensin II-dependent hypertension model in 2K1C mice to evaluate the effects of Kef-1.
What this study cannot tell us
The study was conducted in mice, and results may not directly translate to humans. Further research is needed to confirm efficacy in human populations.
How to read the evidence
This is a preclinical study using a well-established mouse model of hypertension (2K1C) with both in vivo and in vitro components. The 'Preliminary' grade reflects that while the animal results are promising, no human data exists for Kef-1 specifically.
When this study was published
Published in 2022 in Food & Function, this is a recent study in the growing field of food-derived bioactive peptides. The findings are current and reflect modern analytical approaches to nutraceutical research.
The bigger picture
Food-derived bioactive peptides — from kefir, milk, fish, and other sources — are an increasingly active area of research in cardiovascular health. ACE-inhibitory peptides produced during fermentation may partly explain why fermented dairy consumption is associated with lower blood pressure in observational studies. Kef-1 adds to a growing library of food peptides that could become nutraceutical interventions for hypertension.
Questions still open
- Does drinking kefir provide enough Kef-1 to produce meaningful blood pressure effects in humans?
- How does Kef-1's ACE inhibitory potency compare to prescription ACE inhibitors like lisinopril?
- Could Kef-1 be developed as a nutraceutical supplement for mild hypertension?
Common questions
What is Kef-1 and how does it relate to drinking kefir?
Could this peptide replace blood pressure medication?
Read the original research
Use of kefir peptide (Kef-1) as an emerging approach for the treatment of oxidative stress and inflammation in 2K1C mice.
Food & function, 13(4), 1965-1974
Citation
Aires, Rafaela; Gobbi Amorim, Fernanda; Côco, Larissa Zambom; da Conceição, Amanda Pompermayer; Zanardo, Tadeu Ériton Caliman; Taufner, Gabriel Henrique; Nogueira, Breno Valentim; Vasquez, Elisardo Corral; Melo Costa Pereira, Thiago; Campagnaro, Bianca Prandi; Dos Santos Meyrelles, Silvana. (2022). Use of kefir peptide (Kef-1) as an emerging approach for the treatment of oxidative stress and inflammation in 2K1C mice.. Food & function, 13(4), 1965-1974. https://doi.org/10.1039/d1fo01798e